ProJect Pharmaceutics receives CIR application (Research Tax Credit) for the benefit of its French customers
ProJect Pharmaceutics is a contract research and development organization (CRO) specialized in formulation and process development for parenteral drug products. Expanding the offering of its service portfolio towards the French customer base, ProJect Pharmaceutics was engaged to apply at the French Ministère de L’Enseignement Supérieur, De La Recherche Et De L’Innovation for eligibility to join […]
Business Continuity Statement in the course of the global SARS-CoV-2 pandemic
Dear customers of ProJect Pharmaceutics, We understand that all of us are facing exceptional times due to the Corona pandemic. Knowing about the important role our employees play in our customers projects for developing innovating therapeutics, we try to deliver in these challenging times as much as possible, on-site as well as from home office. […]
ProJect Pharmaceutics enters into collaboration with business partners in Asia
ProJect Pharmaceutics is delighted to expand the global presence of its service portfolio towards the Asian market. Entering into a collaboration with business partner BiGEN in South Korea, ProJect Pharmaceutics becomes a cross-country competence hub for formulation and process development. On top, ProJect Pharmaceutics can now offer its clients to act as a gate opener […]
Formulation and lyophilization process development for live virus vaccines
ProJect Pharmaceutics expands its service portfolio to meet customer’s increasing need for the development of GMO S2 and BSL-2 biological products including live viruses. ProJect Pharmaceutics is one of the leading European service providers offering tailored pharmaceutical formulations and lyophilisation processes for therapeutic proteins, peptides and other therapeutic compounds. New safety facilities in dedicated labs […]
ProJect Pharmaceutics enters collaboration with German CMO as the preferred development partner for lyophilization
ProJect Pharmaceutics is a contract research and development organization (CRO) specialized in formulation and process development for parenteral drug products. Adjacent to its service portfolio, ProJect Pharmaceutics operates a broad network towards contract manufacturing organizations (CMOs) for drug substance and drug product to support its clients towards selecting the best fit for their products’ manufacturing […]
High Protein Concentration Formulations
Munich, October 29, 2015 – ProJect Pharmaceutics introduces a science-based approach to develop best-in-class formulations for convenient use in pre-filled syringes Transforming therapeutic proteins into high-concentrated, stable and easy to use medications for subcutaneous self-injection can add up to a major challenge along their clinical development. A formulation’s fundamental qualifications such as appropriate physico-chemical stability, […]
ProJect Pharmaceutics and TUM-Spin-off ImevaX announce agreement on development of pharmaceutical formulation for IMX101
Munich/Martinsried, November, 2013 ProJect Pharmaceutics announces that it has signed a development agreement with ImevaX, a spin-off project from the research group of Prof. Dr. Markus Gerhard from the Technische Universität München, Institute for Medicinal Microbiology, Immunology and Hygiene, aimed at developing a formulation for a recombinant vaccine against Helicobacter pylori. IMX101 is a multicomponent […]
Introducing formulation and lyophilization process development for cytotoxic and other highly potent drugs
ProJect Pharmaceutics expands its service portfolio to meet customer’s increasing need for the development of cytotoxic and other highly potent drugs such as immunotoxins. ProJect Pharmaceutics is one of the leading European service providers offering tailored pharmaceutical formulations and lyophilisation processes for therapeutic proteins and peptides. New safety facilities in dedicated labs and a deep […]
Joint Development of a novel lyophilized Dual Chamber Prefillable Syringe System
Tokyo (Japan) and Munich/Martinsried (Germany), June, 2012 Arte Corporation and ProJect Pharmaceutics have been working closely on the development of a new type of dual chamber prefillable syringe for freeze-dried pharmaceuticals. The two companies have joined together with the objective to provide innovative dual chamber syringes for the global pharmaceutical market. This type of device, […]
Check your Lyo Cycle!
Have you ever calculated the drawback on direct and opportunity costs when your freeze dryer is blocked by lyophilization cycles which take several days? Take this opportunity and have your cycle parameters checked for 2,000 € only. Just send us your lyophilization process parameters, a printout of an actual lyo run and some samples. Our […]